Table 1.
Michigan (n = 92) | Utrecht (n = 130) | |
---|---|---|
Gender | ||
Male | 65 (71) | 92 (71) |
Female | 27 (29) | 38 (29) |
Age (y) | ||
Median | 54 | 58 |
Range | 20-82 | 24-99 |
Tumor site | ||
Larynx | 4 (4) | 47 (36) |
Hypopharynx | 4 (4) | 2 (2) |
Oropharynx | 53 (58) | 41 (31) |
Nasopharynx | 4 (4) | 12 (9) |
Oral cavity | 8 (9) | 11 (8) |
Nasal cavity | 6 (5) | |
Salivary glands | 9 (10) | 1 (1) |
Unknown primary | 4 (4) | 1 (1) |
Other* | 6 (7) | 9 (7) |
Stage (AJCC) | ||
I | 2 (2) | 12 (9) |
II | 12 (13) | 35 (27) |
III | 26 (29) | 30 (23) |
IV | 48 (52) | 36 (28) |
Recurrent/unknown | 4 (4) | 17 (13) |
Radiotherapy | ||
Definitive | 49 (53) | 85 (65) |
Postoperative | 43 (47) | 45 (35) |
Other: (Michigan) skin 4 patients and maxillary sinuses 2 patients; (Utrecht) Hodgkin/non-Hodgkin lymphoma 4 patients, skin/lip 3 patients, orbita 1 patient, upper trachea 1 patient.
Abbreviation: AJCC = American Joint Committee on Cancer Staging Manual (sixth edition, 2002).